WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Thursday, September 6, 2018

Parkinson’s Subtypes Share Early Psychiatric Features, But Diverge as Disease Progresses, Study Suggests

SEPTEMBER 6, 2018 BY DIOGO PINTO




In the early stages, three motor subtypes of Parkinson’s disease share similar psychiatric and cognitive features, with the distinct psychiatric profiles associated with each type only appearing as the disease progresses, a study suggests.
Parkinson’s disease is a diverse neurodegenerative disorder with distinct motor and non-motor symptoms. It is already known that different motor subtypes of the disease evolve with different clinical courses and prognoses.
Parkinson’s can be divided into three main clinical subtypes according to the predominant motor features: tremor-dominant, where tremor is a predominant symptom of the disease; akinetic-rigid or postural instability gait difficulty, characterized by stiffness or inflexibility of the muscles; or mixed, with no prevailing motor features.
Patients diagnosed with akinetic-rigid usually show a faster disease progression and are at higher risk of developing disability and dementia. On the other hand, progression of the tremor-dominant form is slower and associated with less cognitive decline, visual hallucinations, and depression.
These differences are attributed to lower dopamine levels in the brains of akinetic-rigid patients than in those with the tremor-dominant subtype.
Italian researchers studied the psychiatric, cognitive, and motor profiles of these three Parkinson’s subtypes in early, untreated Parkinson’s patients. They used untreated patients to avoid bias of the medication effect.
They included 68 newly diagnosed Parkinson’s patients, of whom 39 were akinetic-rigid, seven were mixed, and were 22 tremor-dominant. The participants underwent a complete assessment of psychiatric symptoms, including depression, anxiety, and apathy; cognitive issues, such as memory, language, attention; and motor features.
No differences were observed among the three Parkinson’s subtypes in any of the psychiatric and cognitive variables assessed. Researchers hypothesize that psychiatric differences among the three motor subtypes are not present in the very early stages of the disease, suggesting that a possible differentiation emerges only over the progression of the disease and potentially with its interaction with dopaminergic replacement therapy.
“This idea is widely supported by the literature on PD patients with longer disease duration and under antiparkinsonian treatment showing greater cognitive deterioration and psychiatric symptoms in AR patients,” the authors wrote.
“The evolution of psychiatric features is not predictable based on early motor presentation and regular follow-ups are needed to investigate their different possible progression,” they concluded.
https://parkinsonsnewstoday.com/2018/09/06/differences-among-subtypes-emerge-parkinsons-progression-study/

No comments:

Post a Comment